Current Edition


Early-stage Development, Xcelodose & Clinical Phases

The pharmaceutical industry’s ongoing demand to shorten drug
development times, thus making significant cost savings, is driving
technological advances forward at the same time as there are major
changes happening in the research and development of highvalue
and often potent speciality medicines. David O’Connell at
PCI Pharma Services explains the effectiveness of Xcelodose®
technology, utilising the latest equipment for the processing of
potent molecules.